Biper Therapeutics

Developer of small molecule drugs for cancer treatment

placeStrasbourg, Grand Est, France calendar_todayFounded 2021 groups7 employees language biper-tx.com

Innovation

5 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 140 times.

YearFilings
20231
20243
20255

Social engagement

Social engagement: 2.2K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Accelerator & incubator125%
Bank & private debt125%
Other / undisclosed125%

Recent activity

5 Jan 2026
Milestone
regulatory
12 Nov 2025
Event
London London Life Sciences Week 17-20 Nov
28 Sep 2025
Event
BIOJapan2025 conference
Coming soon